Načítá se...
Nano-sized carriers in gene therapy for renal fibrosis in vivo
Renal fibrosis is the final common pathway leading to end-stage renal failure regardless of underlying initial nephropathies. No specific therapy has been established for renal fibrosis. Gene therapy is a promising strategy for the treatment of renal fibrosis. Nano-sized carriers including viral vec...
Uloženo v:
Vydáno v: | Nano Rev Exp |
---|---|
Hlavní autoři: | , , , , |
Médium: | Artigo |
Jazyk: | Inglês |
Vydáno: |
Taylor & Francis
2017
|
Témata: | |
On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6167027/ https://ncbi.nlm.nih.gov/pubmed/30410705 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/20022727.2017.1331099 |
Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|